# Tobias Wirenfeldt Klausen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tobias-wirenfeldt-klausen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,110 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 40 |
| i10-index | 106 |
| Last Known Institution | Copenhagen University Hospital |
| OpenAlex ID | https://openalex.org/A5026139263 |
| ORCID iD | 0000-0002-1339-3275 |
| Works | 219 |

## Researcher papers

- [Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia](https://scholariq.org/papers/results-of-nopho-all2008-treatment-for-patients-aged-1-45-years-with-acute/)
- [A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma](https://scholariq.org/papers/a-phase-1-2-trial-of-an-immune-modulatory-vaccine-against-ido-pd-l1-in/)
- [Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients](https://scholariq.org/papers/rituximab-in-chronic-cold-agglutinin-disease-a-prospective-study-of-20-patients/)
- [Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia](https://scholariq.org/papers/rituximab-and-dexamethasone-vs-dexamethasone-monotherapy-in-newly-diagnosed/)
- [A phase <scp>III</scp> randomized trial comparing glucocorticoid monotherapy <i>versus</i> glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia](https://scholariq.org/papers/a-phase-scp-iii-scp-randomized-trial-comparing-glucocorticoid-monotherapy-i/)
- [Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocol](https://scholariq.org/papers/risk-group-assignment-differs-for-children-and-adults-1-45-yr-with-acute/)
- [<scp>MYC</scp> translocation partner gene determines survival of patients with large B‐cell lymphoma with <scp>MYC</scp>‐ or double‐hit <scp>MYC</scp>/<scp>BCL</scp>2 translocations](https://scholariq.org/papers/scp-myc-scp-translocation-partner-gene-determines-survival-of-patients-with/)
- [The Danish National Lymphoma Registry: Coverage and Data Quality](https://scholariq.org/papers/the-danish-national-lymphoma-registry-coverage-and-data-quality/)
- [Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease](https://scholariq.org/papers/comparison-of-techniques-for-monitoring-infliximab-and-antibodies-against/)
- [68Ga-PSMA-PET/CT in comparison with 18F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study](https://scholariq.org/papers/68ga-psma-pet-ct-in-comparison-with-18f-fluoride-pet-ct-and-whole-body-mri-for/)
- [Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study](https://scholariq.org/papers/moderate-antiproteinuric-effect-of-add-on-aldosterone-blockade-with-eplerenone/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

## Researcher university

- [Copenhagen University Hospital](https://scholariq.org/institutions/copenhagen-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.